On Wednesday, the FDA raised concerns about life-threatening hematologic malignancies in patients treated with Bluebird Bio ...

The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

High cumulative doses of epipodophyllotoxins were associated with the highest risk for survivors of childhood cancer of ...

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

The US Food and Drug Administration has received new reports of hematologic malignancies, including life-threatening cases of ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic ...

A Tampa Bay area nurse who was diagnosed with blood cancer had one dying wish – to see the new movie “Wicked" in theaters.

Since approval, the Food and Drug Administration has received additional reports of hematologic malignancies, including ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the ...